JDD Buzz Series | Diversity in Melasma Clinical Trials
Underrepresentation of patients with skin of color in clinical trials is an issue in medical research, including in research about dermatological conditions. A study in the January Journal of Drugs in Dermatology looked at the diversity of patients enrolled in melasma clinical trials to determine if there are any disparities in representation.
I interviewed author Jared Jagdeo, MD, MS, associat …
Underrepresentation of patients with skin of color in clinical trials is an issue in medical research, including in research about dermatological conditions. A study in the January Journal of Drugs in Dermatology looked at the diversity of patients enrolled in melasma clinical trials to determine if there are any disparities in representation.
I interviewed author Jared Jagdeo, MD, MS, associat … Continue reading "JDD Buzz Series | Diversity in Melasma Clinical Trials"
Participating in dermatology research can be a fulfilling part of a dermatologist’s career. So how can a dermatologist start participating in clinical trials? Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Leon Kircik, clinical professor of dermatology at Icahn School of Medicine. Watch as Dr. Kircik shares the three pillars of a cl … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Andrew Alexis, co-chair of Skin of Color Update, and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. Dr. Alexis shares his take on how to address issues of mistrust that may impede clinical trial recruitment in diverse patient populations. Watch as he details why i … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Valerie Callender, professor of dermatology at Howard University School of Medicine. Dr. Callender explains why patients from diverse populations may be hesitant to participate in clinical trials. She shares ways researchers can overcome barriers to recruitment, and why representation among the research team matters. Ac … 
Unfortunately for many residency graduates, a lot of the decisions regarding interactions with industry such as pharmaceutical and medical device sales forces have been made into policies. These are often parallel to the strictures of parents attempting to shelter their children from what is socially perceived as “evil” or “influential,” and in many instances has led to the development … 